Clinical Trials Logo

Filter by:
NCT ID: NCT01670045 Completed - Clinical trials for Rheumatoid Arthritis

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

Start date: March 2012
Phase: N/A
Study type: Observational

This multi-center observational study will evaluate the use and efficacy of RoActemra/Actemra (tocilizumab) in patients with moderate to severe rheumatoid arthritis. Eligible patients initiated on RoActemra/Actemra treatment according to the licensed label will be followed for 6 months.

NCT ID: NCT01654653 Completed - Clinical trials for Coronary Heart Disease

Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients

Start date: July 2008
Phase: Phase 4
Study type: Interventional

The choice of fluid therapy is controversial in cardiac surgery. Numerous studies have shown that colloid is better as compared to crystalloids. Several previous studies have demonstrated that Hypertonic Sodium Lactate (HSL) administration during cardiac surgery shows a promising effect. This study aims to compare hemodynamic effects and fluid balance of HSL with 6% Hydroxy Ethyl Starch (HES).

NCT ID: NCT01651728 Recruiting - Clinical trials for Community-Acquired Pneumonia

Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients

Start date: July 2012
Phase: Phase 3
Study type: Interventional

The objective is to assess the effect of simvastatin on immunology, inflammatory, and coagulation responses, and mortality in elderly with pneumonia based. The primary outcome is mortality event. The hypothesis of this study is that simvastatin therapy will reduce mortality in elderly with pneumonia.

NCT ID: NCT01646437 Completed - Clinical trials for Cardiovascular Disease

The International Polycap Study 3 (TIPS-3)

TIPS-3
Start date: June 2012
Phase: Phase 3
Study type: Interventional

The randomized 2x2x2 factorial design placebo controlled trial will enroll 5000 participants (women 60 years or older and men 55 years or older) without known heart disease or prior stroke and without a clear indication or contraindication to any of the study medications. Eligible and consenting individuals will be randomized to receive either the active study medications or placebo (dummy pills) and will be monitored for an average of 5 years. The study will include people from at 10 countries, will be conducted by an international group of scientists and physicians and will be coordinated by the Population Health Research Institute at Hamilton Health Sciences.

NCT ID: NCT01645332 Completed - Clinical trials for Type-2-diabetes Mellitus

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

Start date: July 2012
Phase: Phase 3
Study type: Interventional

This is a 2-arm, double-blind, parallel, randomized, placebo-controlled clinical study, with 12 weeks of therapy to evaluate the efficacy and safety of DLBS3233 in improving metabolic control in newly diagnosed type-2-diabetic patients, as measured by A1c level, fasting and 2-hours post-prandial plasma glucose, fasting insulin level, HOMA-IR, HOMA-B, adiponectin level, lipid profile, and body weight.

NCT ID: NCT01633398 Completed - Heart Failure Clinical Trials

ASIAN HF Registry, A Prospective Observational Study

ASIANHF
Start date: September 2012
Phase:
Study type: Observational

The ASIAN HF Registry is the first prospective multinational Asian registry of patients with symptomatic HF (stage C) including both HFrEF (ejection fraction <40%) and HFpEF (ejection fraction ≥50%), with the broad purpose of determining the mortality (incidence) burden of HF in Asian patients, and more specifically to define the burden and risk factors of Sudden Cardiac Deaths (SCD), as well as the sociocultural barriers to preventive device therapy. The study further aim to study the genetic variants associated with HFrEF versus HFpEF in our large Asian cohort. This proposed registry is expected to advance fundamental understanding of the burden and predictors of preventable death among Asian patients with HF. The knowledge gained will be critical for guiding resource allocation and planning preventive strategies to address the unmet and growing clinical needs of patients with cardiovascular disease in Asia.

NCT ID: NCT01626625 Recruiting - Healing of Fracture Clinical Trials

Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture

Start date: April 2010
Phase: Phase 1
Study type: Interventional

The investigators hypothesized that mesenchymal stem cells can be isolated from fracture site, iliac crest, and tibial crest, and can be expanded to be used in the management of nonunion fracture.

NCT ID: NCT01624324 Recruiting - Ototoxicity Clinical Trials

Aminoglycoside Plasma Level Measurement in Neonates With Infection

Start date: November 2010
Phase: N/A
Study type: Observational

The aim of this study is to determine whether the plasma concentration of aminoglycoside in Indonesia neonates with infection are within safe and effective range and its association with cochlear toxicity and nephrotoxicity.

NCT ID: NCT01602055 Completed - Fasting Clinical Trials

A Bioequivalence Study of Two Azithromycin Tablet Formulations in Indonesian Healthy Subjects

Start date: October 2010
Phase: Phase 1
Study type: Interventional

The aim of this study is to assess the bioequivalence of 500 mg Azithromycin FC tablets (Azivol) produced by PT. Novell Pharmaceutical Laboratories, compared to the reference product Zithromax 500 mg FC tablet produced by Pfizer Australia Pty, Ltd

NCT ID: NCT01597076 Completed - Quality of Life Clinical Trials

Effect of an Iridoid Enriched Beverage on Skin Autofluorescence

Start date: May 2012
Phase: Phase 1
Study type: Interventional

The objectives of this clinical trial are to evaluate the effectiveness of an iridoid enriched beverage containing noni and cornelian juices and olive leaf extract on advanced glycation end product levels.